Annual Report 2017

Lary 1 AB

We want to empower our end-users!

2017 was an exciting year for Atos Medical. This year, we expanded our global field sales force, invested aggressively in our Direct to Consumer setup, launched an entirely new product category with Provox Luna, and completed six acquisitions of local distributors.

Word from CEO

Financial highlights 2017

12%

Total revenue growth

15%

Laryngectomy revenue growth

80%

Adjusted Gross margin excl. depreciation

40%

Adjusted EBITDA margin

Your Voice

Our commitment to meeting the highest standards in laryngectomy care is built on a deep understanding of user needs – through listening and learning. With a long list of innovations, we have been dedicated to making a difference to users for over thirty years.

Find out how we connect with our users and improve their quality of life